FLEMINGTON, N.J.--(BUSINESS WIRE)--On December 2, 2009, NovaDel Pharma Inc. (the “Company”) (NYSE AMEX: NVD) notified NYSE Amex LLC (“Exchange”) of its intent of voluntarily delist its common stock from the Exchange. The Company anticipates that the delisting will be effective 10 days after filing of the Form 25, “Notification of Removal from Listing.” The Company intends to file Form 25 on or after December 14, 2009. The Board of Directors of the Company approved the voluntary delisting of the Company’s common stock on October 15, 2009. Upon delisting from the Exchange, the Company intends to have its common stock quoted on the OTC Bulletin Board (“OTCBB”).
